Skip to content

Dossier · GRPN · Dormant

GRPN · Groupon, Inc. · Stock research

Last analysed ·

Current thesis

AI-native restructuring re-rate — up to 400 job cuts, FY26 EBITDA guide raised to $75–80M — plus a low-float, Russell-inclusion squeeze that popped GRPN +10% on 2026-07-16. But Q1 billings fell 1% YoY and sell-side sits at Sell: a maturing turnaround with squeeze optionality, with the ~2026-08-06 Q2 print as the binary.

Invalidation trigger

A weekly close below $22 surrenders the mid-July Russell-inclusion squeeze base and signals the passive bid plus short-covering have exhausted; a Q2 print near 2026-08-06 with billings below flat or a cut to the raised $75–80M EBITDA guide confirms the turnaround has stalled.

Thesis status

Open commitment catalyst 3d agoscored if the trigger above fires How this is scored →

Latest analysis and events for GRPN —

As of 2026-07-25, orbyd's latest analysis for Groupon, Inc. (GRPN): AI-native restructuring re-rate — up to 400 job cuts, FY26 EBITDA guide raised to $75–80M — plus a low-float, Russell-inclusion squeeze that popped GRPN +10% on 2026-07-16. But Q1 billings fell 1% YoY and sell-side sits at Sell: a maturing turnaround with squeeze optionality, with the ~2026-08-06 Q2 print as the binary.

Invalidation trigger: A weekly close below $22 surrenders the mid-July Russell-inclusion squeeze base and signals the passive bid plus short-covering have exhausted; a Q2 print near 2026-08-06 with billings below flat or a cut to the raised $75–80M EBITDA guide confirms the turnaround has stalled.

Most recent dated event on file: — catalyst 3d ago.

Current Thesis

The investable leg is an "AI-native" restructuring re-rate stacked on squeeze mechanics. In late May 2026 management announced cutting up to 400 roles (~15% of global headcount) for $20–25M of annual savings, which lifted the FY26 adjusted-EBITDA guide to $75–80M (from $70–75M) alongside a stated goal of at least $60M free cash flow. Layered on a heavily-shorted low float and a late-June reclassification into the Russell Value indices, that produced a +10% squeeze on 2026-07-16. The problem: Q1 2026 global billings fell 1% YoY with revenue flat, sell-side consensus is Sell, the average 12-month target ($26.33) sits essentially at spot ($25.81), and the stock trades ~40% under its $43.08 52-week high. This is a maturing turnaround carrying squeeze optionality rather than an accelerating narrative — the ~2026-08-06 Q2 print is the arbiter.

Bullish and bearish views on Groupon, Inc.

The model's bull view on Groupon, Inc. (GRPN), in brief: FY26 adjusted-EBITDA guide raised to $75–80M and a stated FCF target of at least $60M with billings +3–5% (Q1 2026 commentary). The bear view: Growth is decelerating: Q1 2026 global billings −1% YoY and revenue flat, with North America local slowing — the inverse of the setup this book exists to catch. Both cases follow in full.

Bull Case

  • FY26 adjusted-EBITDA guide raised to $75–80M and a stated FCF target of at least $60M with billings +3–5% (Q1 2026 commentary). A first genuinely FCF-positive year re-rates a former value trap off a low base.
  • The cost lever is dated and concrete: up to 400 roles (~15% of headcount) cut for $20–25M annual savings, announced late May 2026, dropping largely to EBITDA in a business that already finished its cloud re-platform.
  • Squeeze fuel is real: a large portion of the float sits short, and the late-June 2026 move into the Russell Value indices forced passive buying that drove the +10% pop on 2026-07-16. A billings/EBITDA beat on ~2026-08-06 into that positioning can force covering toward the $40 Street high.
  • Capital return that tightens the float: 2.8M shares repurchased in Q1 2026, shrinking an already-small tradeable share count.
  • Project Foundry — embedding AI agents into SEO, app development, and merchant acquisition via voice agents — hands the tape a fresh label distinct from the dead "daily deals" frame.

Bear Case

  • Growth is decelerating: Q1 2026 global billings −1% YoY and revenue flat, with North America local slowing — the inverse of the setup this book exists to catch.
  • Sell-side consensus is Sell as of 2026-07-16, and the average target $26.33 sits at the $25.81 price — there is no analyst-upgrade runway to front-run.
  • Management instability mid-restructuring: COO Jiri Ponrt resigned effective 2026-07-10, raising execution risk on the very cost plan the bull case leans on.
  • The 2026-07-16 advance was a mechanical squeeze on index rebalancing, not a fundamental inflection; those fade once the passive bid completes and shorts re-establish.
  • Q2 consensus EPS is −$0.06 — still loss-making at the reported line; a repeat of the Q1 weather excuse or a billings print below flat would erode the raised EBITDA guide's credibility.
  • Price is ~40% under the $43.08 52-week high in a sloppy mid-range structure; "cheap versus the high" is an anchor, not a setup.

Setup & Price Structure

  • Last $25.81 (2026-07-24); day range $25.23–$26.49; 52-week range $9.17–$43.08.
  • The name has already run a full mania cycle ($9 → $43 → mid-$20s) and now trades mid-range — above the July squeeze base but far below the highs, with no clean higher-low breakout and no peer cluster confirming (Groupon is idiosyncratic; there is no local-commerce peer group breaking out alongside it).
  • The 2026-07-16 +10% squeeze built a near-term shelf in the low-$20s; holding it keeps the squeeze leg alive, losing it hands the tape back to shorts.
  • The $26.33 average target caps consensus upside, with the $40 high estimate as the squeeze-case ceiling and the $13 low estimate marking the bear downside.
  • For a fresh entry this reads as stand-aside-until-it-bases-or-prints: a fat float-adjusted range and a binary print roughly eight sessions out mean chasing the squeeze here is buying into an event, so waiting for a base or the number is the higher-quality path.

Catalyst Calendar (next 30 days)

  • ~2026-08-06 (est.) — Q2 2026 earnings after the close (one source cites 2026-08-12; confirm the date). Consensus EPS −$0.06. The print grades the raised $75–80M EBITDA guide, the billings trajectory against the Q1 −1%, and whether the 400-role cut is flowing through. This is the binary.
  • Ongoing — Russell Value index flows from the late-June inclusion; passive rebalancing can persist into the print and amplify moves in a low float.

Elapsed catalysts

  • Watch — any 8-K on further restructuring (Q1 flagged a "potential 15% headcount reduction") or additional executive departures following the 2026-07-10 COO exit. (passed 30d ago)

What Would Change Our Mind

Bull-confirm: a Q2 print (~2026-08-06) with billings back to positive YoY and the $75–80M EBITDA / $60M FCF guide reaffirmed or raised, holding a weekly close above the mid-$20s squeeze shelf, would flip the read from maturing to re-accelerating and justify sizing up. Thesis break: a weekly close below $22 surrenders the mid-July Russell-inclusion squeeze base and signals the passive bid and short-covering have exhausted; a Q2 billings print below flat or a trim to the raised $75–80M EBITDA guide converts the AI-restructuring story back into a value trap.

Correlation Notes

  • Idiosyncratic name: GRPN moves on company-specific squeeze mechanics and restructuring headlines, not on a consumer-discretionary factor beta — the "consumer-discretionary-rotation" tag is a loose classifier rather than a tradable cluster.
  • Behaves like a low-float short-squeeze vehicle, correlated more to short-interest and borrow-cost dynamics and to index-rebalancing flow than to XLY or any local-commerce peer set.
  • Sentiment reads off retail squeeze chatter and borrow availability rather than sell-side, which sits at Sell (2026-07-16) with the average target pinned at spot.

Notes

  • Q2 2026 earnings ~2026-08-06 after close (one source says 2026-08-12) — confirm date; avoid fresh entries into the print given low float + binary risk.
  • Low float + elevated short interest: moves are squeeze-driven (July 16 +10% on Russell Value index inclusion). Size tight, probe only, never chase the pop.
  • Sell-side at Sell (2026-07-16); avg 12-mo PT $26.33 ~ at spot $25.81 — no analyst-upgrade runway to front-run. High estimate $40, low $13.
  • COO Jiri Ponrt resigned effective 2026-07-10 mid-restructuring — watch for further exec departures / 8-K restructuring actions.
  • Q1 2026 was a miss: global billings -1% YoY, revenue flat, North America local decelerating; 2.8M-share buyback executed.

Related · shared themes

HPE

Hewlett Packard Enterprise Company

Five straight up sessions took HPE to a $53.22 close on 2026-08-07 with the 2026-08-04 gap floor at $50.24 still untested; Trefis put the five-day move at +19.8% against +5.6% for the S&P 500, so this leg is no longer pure sector beta. Forward P/E 13.79 versus 49.66 trailing. The still-unconfirmed ~2026-09-02 Q3 print against the $11.5–12.1B / $0.88–0.93 guide is the binary.

MEDIUM

SIMO

Silicon Motion Technology Corporation

Controller-mix decoupling got its first hard datapoint on 2026-08-06 — SIMO +8.42% to $267.43 while Western Digital fell 16% and SanDisk 11% on beat-but-guide-light prints — then gave most of it back on 08-07 (-4.23% to $256.12, $18.87 off the high, thinnest volume of the run). Six sessions after a beat-and-raise the ADS sits $1.02 above the 07-30 reaction close; the 50-day at $286.82 is unreclaimed.

MEDIUM

XMTR

Xometry, Inc.

Q2 on 2026-08-04 cleared every self-set number — revenue $229.3M (+41%), marketplace +45%, Adj EBITDA $14.1M — and the new CEO raised FY2026 growth to 33–34% from 27–28%. Price took three sessions to agree, closing $93.15 on 08-07 back above the $90.65 50-day, still under the $106.08 July high.

MEDIUM

ATEX

Anterix Inc.

The 2026-08-04 spectrum re-rating gap has largely round-tripped: $106.35 close, then $99.41, $100.32 and $99.26 through 2026-08-07, heaviest volume on the down day. The 1.0M-share dilution vote passed on 2026-08-04; the 2026-08-11 Q1 print, first disclosure since 2026-06-10, is the binary left.

LOW

See also · stocks to watch